Bastiano Sanna, EVP, Cell & Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,155 shares at $210.44 ($664K) on 2021-02-11, disclosed to the SEC on 2021-02-16.
Open-market sale of $664k VRTX by EVP, Cell & Genetic Therapies. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.44 | 1,469 | $309K | 46.5% |
| 2 | $210.44 | 1,469 | $309K | 46.5% |
| 3 | $211.41 | 217 | $46K | 6.9% |
| Total | $210.51 avg | 3,155 | $664K | 100% |
| Filing → |
| VRTX | SELL | 2023-04-14 | $4.9M | — | Filing → |
| VRTX | SELL | 2023-04-06 | $231K | — | Filing → |
| VRTX | SELL | 2023-03-20 | $1.7M | — | Filing → |